Karl William Smith

Karl William Smith

Auto-generated profile, based on publicly available information

Karl William Smith

Leibniz-Institut für Analytische Wissenschaften—ISAS—e.V, Dortmund, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in ACS Omega
Verified
Journal Article
Closed access
KSKarl W. Smith
Karl W. Smith
BFBryn Flinders
Bryn Flinders
PTPaul D. Thompson
Paul D. Thompson
FCFaye L. Cruickshank
Faye L. Cruickshank
CMC. Logan Mackay
C. Logan Mackay
Diego CobiceDiego Cobice
Diego Cobice

31 July 2025 in Cancer Discovery
Verified
Journal Article
Closed access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression. Significance: Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.

18 October 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
CMC. L. Logan Mackay
C. L. Logan Mackay
JSJens Soltwisch
Jens Soltwisch
BHBram Heijs
Bram Heijs
KSKarl W. Smith
Karl W. Smith
FCFaye L. Cruickshank
Faye L. Cruickshank
Diego CobiceDiego Cobice
Diego Cobice
Prostate cancer is initially treated via androgen deprivation therapy (ADT), a highly successful treatment in the initial pursuit of tumour regression, but commonly restricted by the eventual emergence of a more lethal ‘castrate resistant’ (CRPC) form of the disease. Intracrine pathways that utilize dehydroepiandrosterone (DHEA) or other circulatory precursor steroids are thought to generate relevant levels of growth-stimulating androgens such as testosterone (T) and dihydrotestosterone (DHT). Decoding this tissue-specific metabolic pathway is key for the development of novel therapeutic treatments. Mass spectrometry imaging (MSI) is an analytical technique that allows the visualization of the distribution of numerous classes of biomolecules within tissue sections. The analysis of androgens by liquid chromatography mass spectrometry (LC/MS)-based methods however presents a challenge due to their generally poor ionization efficiency and low physiological endogenous levels. In MSI, on-tissue chemical derivatization (OTCD) has enabled the limits of steroids to be imaged within tissues to be pushed by overcoming poor ionization performance. However, isobaric interference of key androgen derivatives such as T and DHEA can severely hamper studying the intracrinology in several diseases. Here, we have evaluated the use of laser induced post-ionization (MALDI-2) combined with trapped ion mobility separation (TIMS) and orthogonal time-of-flight (QTOF) MS for the visualization of isobaric derivatized androgens in murine tumour xenograft at about 50 μm spatial resolution. With this combination, isobaric T and DHEA were separated in tissue sections and the signals of derivatized steroids enhanced by about 20 times. The combination of TIMS and MALDI-2 thus shows unique potential to study tissue intracrinology within target tissues. This could offer the opportunity for many novel insights into tissue-specific androgen biology.

13 May 2025 in Analytical Chemistry
Verified
Journal Article
Open access
SKSiva Swapna Kasarla
Siva Swapna Kasarla
AFAntonia Fecke
Antonia Fecke
KSKarl William Smith
Karl William Smith
VFVera Flocke
Vera Flocke
UFUlrich Flögel
Ulrich Flögel
Prasad PhapalePrasad Phapale
Prasad Phapale
Imaging small polar metabolites and analyzing their in vivo dynamics with stable isotope-labeled (SIL) tracing through various biochemical pathways, including the citric acid (TCA) cycle, glycolysis, and amino acid metabolism, have gained substantial interest over the years. However, imaging these small polar metabolites across different tissue types is limited due to their lower ionization efficiencies and ion suppression from larger abundant biomolecules. These challenges can be further exacerbated with SIL studies, which require improvements in sample preparation and method sensitivity. Solvent pretreatments before matrix application on a tissue section have the potential to improve the sensitivity of metabolite imaging; however, they are not yet widely optimized across tissue types. Furthermore, there is a recurring concern about metabolite delocalization from such wash treatments that require "spatial validation". Here, we optimized a simple "basic hexane" wash method that improved sensitivity up to several folds for a broad range of polar and 2H-labeled metabolites across five different mouse organ tissues (kidney, heart, brain, liver, and brown adipose tissue). Notably, we provided region-specific quantification of 51 metabolites using laser microdissection (LMD)-LC-MS/MS to validate their localization observed in MALDI-MSI analysis after the basic hexane wash. Overall, we reported an improved MALDI-MSI sample pretreatment method with a "spatial validation" workflow for sensitive and robust imaging of polar metabolite distributions in mouse organs.

1 November 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KSKarl W. Smith
Karl W. Smith
PTPaul D. Thompson
Paul D. Thompson
EREdna Patricia Rodriguez
Edna Patricia Rodriguez
LMLogan Mackay
Logan Mackay
Diego CobiceDiego Cobice
Diego Cobice

28 April 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
KSKarl W. Smith
Karl W. Smith
AFAntonia Fecke
Antonia Fecke
SKSiva Swapna Kasarla
Siva Swapna Kasarla
Prasad PhapalePrasad Phapale
Prasad Phapale